cyclin dependent kinase 2 inhibitors (GPC Biotech)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namecyclin dependent kinase 2 inhibitors (GPC Biotech)
Drug Alias NameCDK2 inhibitors (GPC Biotech Inc)GPC-285953GPC-286051GPC-286022GPC-286060 +[7] 
ClassificationSmall molecules
Mechanisms of ActionCyclin-dependent kinase 2 inhibitorsAnticancer protein kinase inhibitors
TargetsCyclin-dependent kinase 2
Therapy Area/IndicationsInflammationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGpc Biotech
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGpc Biotech
Active IndicationsN/A
Inactive IndicationsInflammationNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A